Form D · Other

Cybrexa Holding Company, LLC

New Haven, CT · CIK 0001753776

Offering snapshot reported Jun 24, 2022 · SEC filing

Reported sold: $40.2M
Investors reported: 20
Minimum accepted: $0
First sale: Dec 29, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$14,888,346 → $40,242,066
Reported investors13 → 20

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 24, 2022	Amendment	$40,242,066	$25,353,720vs Dec 31, 2020	20	SEC filing
Nov 16, 2021	Amendment	$31,224,405	$16,336,059vs Dec 31, 2020	13	SEC filing
Dec 31, 2020	Initial	$14,888,346	No comparison	13	SEC filing
Jan 23, 2020	Initial	$1,700,000	No comparison	1	SEC filing
Sep 21, 2018	Initial	$499,999	No comparison	1	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $75K
Finders' fees: $0
Form D file number: 021-384930

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
BFC Group Ltd.	None

Source: Form D, filed Jun 24, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
F. Kevin Didden	Director
Michael Grillo	Director
Per Hellsund	Director, Executive
John Houston	Director
Kevin L. Rakin	Director

Issuer details

Industry: Other (See others in industry)

Address:

5 Science Park 395 Winchester Avenue
New Haven, CT, 06511